China's medical unicorns ranked large, with 22 companies on the list.

Pharmaceutical Network Industry Dynamics Recently, Hurun Research Institute released the "Suzhou High-tech Zone 2020 Hurun Global Unicorn List."
lists unlisted companies worth more than $1 billion worldwide since the 2000 establishment of March 31, 2020.
, a total of 47 unicorn companies involved in the medical and health sectors are listed in the two sub-sectors of biotechnology and health technology.
specifically, China has 22 more companies than the United States has 18.
of them are seven U.S. companies in the biotech industry, six in China, while China's advantage in the health technology industry is even more pronounced, with 16 companies outnumbering 11 in the U.S.
, however, it is well known that in the biotechnology industry, although the number of companies between China and the United States is not large (one) but in terms of value of Chinese enterprises and the United States gap is still very large.
in health care, the gap is slowly narrowing.
industry believes that the 22 Chinese pharmaceutical unicorns on the list may lead the future of the healthcare industry.
for this, the author also specially combed the list of the value of more than 30 billion yuan in the development of medical health enterprises, with you to share their development in the development of what the bright spots.
Ping An Health Insurance Technology: 60 000 (RMB100 million) Ping An Medical Insurance Technology was established in September 2016, is the younger force in the number of "unicorns" hatched by Ping An in recent years.
it to the payer as the entrance, to the service provider extension, is committed to reforming china's medical market, to help the "three medical linkage", to achieve "one drop two mention."
years of practice, by the end of 2019, its business market has covered nearly 30 provinces and more than 200 cities in china, providing services to 800 million members of the public.
it is understood that last year Ping An Health Insurance Technology has been able to empower the domestic medical ecosystem of the new state of development and up to 8.8 billion U.S. dollars after the investment market strongly ranked in the global unicorn enterprises 500 33rd.
JD.com Health: In recent years, JD.com Health has provided digital empowerment programs for industrial, commercial and terminal sectors of pharmaceutical circulation, completed infrastructure construction including pharmaceutical, non-drug supply chain capacity, pharmaceutical logistics, supply chain finance, and built industrial sales systems, B2B trading systems, commercial data analysis technology products, and activated digital pharmaceutical sales channels through national terminal coverage, natural person model, JD.com, and Beijing-East Internet.
according to the relevant person in charge, JD.com Health in the future will further improve the competitiveness of terminal operations through six core capabilities, such as drug Beijing, JD.com, drug clinics, big data analysis, intelligent hardware experience slow disease management zone, live channel sinking, etc.
Micromedicine: 40 000 (RMB100 million) worth of micromedicine was founded in 2010, the current scope of business covers insurance, online appointments and offline clinics.
in February this year, according to public information, the cumulative registered users of micro-medical has reached 210 million, connecting more than 3,200 hospitals, 310,000 doctors, a total of 990 million patients.
, according to vcbeat reported that the chairman and CEO of micro-medical Liao Jieyuan said earlier that in 2016 micro-medical revenue has exceeded 1.2 billion yuan, medical, insurance, medicine three major industries to achieve profits, revenue accounted for 45%, 35%, 20%, profits mainly from insurance.
Micromedicine is one of the few Internet medical head companies that publicly claims to be profitable in many ways.
but because micromedicine is not listed, the statistical calibre of each company may be different, the specific profit situation is not yet known.
: 300 million yuan worth of Conocosic Healthcare was established in 2011 and is a high-end provider of medical imaging equipment.
as a scientific and technological innovation enterprise in Shanghai, once thought to be expected to become a beneficiary of the board.
at present, its production of high-end medical imaging diagnostic products, precision radiotherapy products and uCloud cloud intelligent medical cloud and other products, is the representative of domestic high-end medical equipment.
.